Novel pre-clinical results regarding OncoSec's intratumoral electroporation platform were highlighted as Editor's Pick in Molecular Cancer Research Jun 24, 2022 8:00am EDT
OncoSec Receives Triple Negative Breast Cancer Foundation's Vanguard Award for Excellence in Oncology Research May 23, 2022 8:00am EDT
OncoSec Medical Hosting SITC Key Opinion Leader Webinar on Updated Data from the KEYNOTE-695 Study Nov 02, 2021 8:00am EDT
OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference Jul 26, 2021 8:30am EDT
OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma Jul 06, 2021 4:01pm EDT
